ACUTAASPharmaceuticals
ACUTAAS CHEMICALS LIMITED — PE Ratio & Valuation Analysis
₹2558.60
+0.70%
Current P/E64.86xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E172.1x62.3% below avg
⚠️
104.2% Premium to Industry
ACUTAAS P/E 64.86x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹9.90 | ₹1705 | 172.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding ACUTAAS CHEMICALS LIMITED Valuation
ACUTAAS CHEMICALS LIMITED (ACUTAAS) currently trades at 64.86x earnings. The Pharmaceuticals sector average PE is 31.77x. ACUTAAS commands a premium, reflecting high growth expectations. Historically, ACUTAAS has traded at an average PE of 172.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.00%
Dividend Yield
0.08%
More on ACUTAAS CHEMICALS LIMITED
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.